Grenoble, France, 28 September, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, today announced the closing of a second funding round of USD 4.7M (EUR 3.2M). New investor, Auriga Partners, led the round. An existing investor Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also took part.
CYTOO will use the financing to grow its business internationally, expand the team and further its research and development in an area that is attracting increasing scientific and industrial interest.
“We are very...